These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7925137)

  • 21. Effect of YM934, a KATP channel opener, on airway hyperresponsiveness induced by platelet activating factor in guinea-pigs.
    Saitoh C; Ishikawa J; Asano M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):203-9. PubMed ID: 9050013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose halothane produces airway dilatation but does not alter parenchymal mechanics in the normal canine lung.
    Sato J; Shinozuka N; Kochi A; Uchida H; Mizuguchi T
    Can J Anaesth; 1995 May; 42(5 Pt 1):438-45. PubMed ID: 7614655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway and tissue mechanics during physiological breathing and bronchoconstriction in dogs.
    Lutchen KR; Suki B; Zhang Q; Peták F; Daróczy B; Hantos Z
    J Appl Physiol (1985); 1994 Jul; 77(1):373-85. PubMed ID: 7961260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.
    Fang W; Zhang R; Sha L; Lv P; Shang E; Han D; Wei J; Geng X; Yang Q; Li Y
    J Neurochem; 2014 Mar; 128(5):662-71. PubMed ID: 24164378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAF increases hepatic vascular resistance and glycogenolysis in vivo.
    Hines KL; Braillon A; Fisher RA
    Am J Physiol; 1991 Mar; 260(3 Pt 1):G471-80. PubMed ID: 1848410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves.
    Van de Weerdt ML; Husson C; Lekeux P
    Zentralbl Veterinarmed A; 1999 Mar; 46(2):103-13. PubMed ID: 10216447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs.
    Shibamoto T; Yamaguchi Y; Hayashi T; Saeki Y; Kawamoto M; Koyama S
    Am J Physiol; 1993 May; 264(5 Pt 2):H1454-9. PubMed ID: 8498559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat.
    Clavijo LC; Carter MB; Matheson PJ; Wilson MA; Wead WB; Garrison RN
    J Appl Physiol (1985); 2001 Jan; 90(1):261-8. PubMed ID: 11133918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine.
    Ohar JA; Pyle JA; Waller KS; Hyers TM; Webster RO; Lagunoff D
    Am Rev Respir Dis; 1990 Jan; 141(1):104-10. PubMed ID: 2297169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of platelet-activating factor on the responsiveness of the human nasal airway.
    Austin CE; Foreman JC
    Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid inhibition of airway microvascular leakage.
    Boschetto P; Rogers DF; Fabbri LM; Barnes PJ
    Am Rev Respir Dis; 1991 Mar; 143(3):605-9. PubMed ID: 2001074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation.
    Falk S; Göggel R; Heydasch U; Brasch F; Müller KM; Wendel A; Uhlig S
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1734-42. PubMed ID: 10556149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Distribution of platelet activating factor in the pulmonary tissues of normal rats].
    Cheng D; Chen W
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):300-3. PubMed ID: 8586397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.